1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases : A field that needs to be closely studied
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Ezetimibe Inhibits Expression of Acid Sphingomyelinase in Liver and Intestine.
(
- Contribution to journal › Article
- 2008
-
Mark
Dietary Sphingomyelin Inhibits Colonic Tumorigenesis with an Up-regulation of Alkaline Sphingomyelinase Expression in ICR Mice
(
- Contribution to journal › Article
- 2006
-
Mark
Phospholipid signals and intestinal carcinogenesis
(
- Contribution to journal › Article
- 2005
-
Mark
Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells
(
- Contribution to journal › Article
- 2004
-
Mark
Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild type enzyme in Caco-2 cells.
(
- Contribution to journal › Article